Predict your next investment

Corporation
HEALTHCARE | Biotechnology
clovisoncology.com

See what CB Insights has to offer

Founded Year

2009

Stage

PIPE | IPO

Total Raised

$145M

Market Cap

0.35B

Stock Price

2.71

About Clovis Oncology

Clovis Oncology is developing cancer treatments for certain patients who have metastatic pancreatic cancer, non-small cell lung cancer, and various solid tumors. The Company is focused on licensing or acquiring rights to oncology compounds in all stages of clinical development.

Clovis Oncology Headquarter Location

5500 Flatiron Parkway

Boulder, Colorado, 80301,

United States

303-625-5000

Latest Clovis Oncology News

Clovis expects Rubraca sales slip for full-year 2021

Jan 11, 2022

Cancer-drug manufacturer Clovis Oncology Inc. is projecting revenues between $148.3 million and $148.9 million for the full 2021 fiscal year, a significant drop from $164.5 million in revenue the prior year.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Clovis Oncology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Clovis Oncology is included in 1 Expert Collection, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Clovis Oncology Patents

Clovis Oncology has filed 8 patents.

The 3 most popular patent topics include:

  • Antineoplastic drugs
  • Alkylating antineoplastic agents
  • Cancer treatments
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/14/2018

11/20/2018

Dosage forms, Pharmaceutical industry, Fluoroarenes, Antineoplastic drugs, Drug delivery devices

Grant

Application Date

3/14/2018

Grant Date

11/20/2018

Title

Related Topics

Dosage forms, Pharmaceutical industry, Fluoroarenes, Antineoplastic drugs, Drug delivery devices

Status

Grant

Clovis Oncology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Clovis Oncology Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.